Michael Gilson
Lawyers
Advises U.S. and international corporate and private equity clients on a full range of public and private transactions, both domestic and cross-border.
Michael advises U.S. and international corporate and private equity clients on a full range of public and private transactions, both domestic and cross-border. His experience includes mergers, acquisitions, investments, joint ventures, collaborations, spinoffs, restructurings, special committee representations, and defensive and corporate governance advice.
Admitted to practice only in New York and England and Wales.
Experience highlights
Strategic Company Mergers & Acquisitions
- Roper Technologies on various transactions including its $3.725 billion acquisition of Frontline Education
- Shire’s £46 billion acquisition by Takeda
- Takeda disposition of Xiidra®
- Sale of TiGenix to Takeda
- Clarivate’s $6.8 billion combination with CPA Global
- Sitio Royalties $4.8 billion all-stock merger with Brigham Minerals
- Sale of Numerix to GenStar Capital
- Sale of Services Group of America to US Foods
- Dufry’s going-private acquisition of Hudson
- Reckitt’s acquisition of Biofreeze
Private Equity
- TPG on various transactions, including its $1 billion IPO
- Elliott Management on various transactions including the sale of AC Milan to RedBird Capital Partners
- Tailwind Capital on various transactions including its acquisition of Abode Healthcare
- A consortium of investors on an unsuccessful bid for Chelsea FC
- Cerberus Capital Management investment in Comscore
- Evergreen- and Brookfield-led consortium $16 billion acquisition of Nielsen
Insights
Education
LL.M., McGill University
B.A., Law, University of Cambridge
Professional history
- Partner, 2022-present
- London office, 2014-2016
- Davis Polk since 2014
Qualifications and admissions
- England and Wales
- State of New York